STAT Plus: Pharmalittle: Researchers identify 70 drugs for possibly fighting Covid-19; Gilead pauses access to experimental drug
Good morning, everyone, and how are you today? We hope the weekend break was something…
Category: pharmalittle
STAT Plus: Pharmalittle: Trump adviser slams PhRMA pushback against ‘American-made’; drug makers boost production of malaria pill for Covid-19
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Pharmalittle: WHO to launch expansive coronavirus clinical trial; FDA halts some domestic inspections
Rise and shine, everyone, another intense day is on the way. The world seems to…
STAT Plus: Pharmalittle: Blood samples are lacking for coronavirus treatments; Europe counters Trump offer to vaccine maker
Good morning, everyone, and welcome to the middle of the week. You made it this…
STAT Plus: Pharmalittle: FDA gives states an OK to authorize coronavirus tests; more companies race to combat Covid-19
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT Plus: Pharmalittle: Drug makers scramble to develop Covid-19 vaccines; Qiagen vows to ramp up production of test chemical
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Pharmalittle: A move to fund U.S. production of pharma ingredients; White House issues ‘principles’ for drug pricing reform
Good morning, everyone, and how are you today? We are coping, thank you, despite the…
STAT Plus: Pharmalittle: Shortage of a key chemical slows coronavirus testing; CMS touts pilot program to lower insulin costs
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT Plus: Pharmalittle: Gates Foundation and others plan $125 million coronavirus effort; India considers lifting export restrictions
Rise and shine, everyone, another busy day is clearly on the way. The world seems…
STAT Plus: Pharmalittle: Will some coronavirus vaccines make infections worse? Not all biopharma execs have prepared
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Pharmalittle: Coronavirus vaccine testing starts in Seattle area; New Mexico law caps monthly insulin co-pay at $25
Hello, everyone, and how are you today? We are doing just fine, thank you, courtesy…
STAT Plus: Pharmalittle: Vaccine affordability a roadblock to coronavirus funding; developing a drug costs how much?
Top of the morning to you and a fine one, it is. A shiny sun…
STAT Plus: Pharmalittle: Trump’s contempt for pharma melts away; India restricts exports of 26 ingredients due to coronavirus
Rise and shine, everyone, another busy day is on the way. We can tell because…
STAT Plus: Pharmalittle: Experts warn political squabbles should not delay coronavirus funding; Gilead to buy Forty Seven for $5 billion
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Pharmalittle: Azar says Medicare is open to price negotiations; drug makers say opioid settlements are in jeopardy
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Pharmalittle: FDA tracks 20 drugs for shortage risk due to coronavirus; GOP senator moves toward Medicare drug negotiations
Top of the morning to you. Another busy day is unfolding here on the Pharmalot…
STAT Plus: Pharmalittle: Moderna ships first batch of coronavirus vaccine; Mallinckrodt to pay $1.6 billion to settle opioid claims
Hello, everyone, and how are you this morning? We are doing just fine, thank you,…
STAT Plus: Pharmalittle: Trump aide wants to bring pharma supply chain home; Walgreens hides prescription errors
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Pharmalittle: Canada may change new rules for drug prices; Trump frustrated over drug pricing
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Pharmalittle: Need cheap insulin? Try Craigslist; Trump warned about monopolies on coronavirus treatments
Rise and shine, everyone, another busy day is on the way. We can tell because…
STAT Plus: Pharmalittle: Prices for active ingredients rise in China due to coronavirus; Grassley presses his drug pricing bill
Top of the morning, and a fine one it is. Warm and sunny skies are…
STAT Plus: Pharmalittle: Coronavirus clinical trials are going slower than hoped; opioid lawsuit payouts may be less than expected
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Pharmalittle: Generic shortages loom as coronavirus worsens; Connecticut lawmakers look to cap insulin costs
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Pharmalittle: India struggles with coronavirus; CVS and Sanofi shake up management
Top of the morning to you, and a fine one, it is. Despite another round…
STAT Plus: Pharmalittle: Big pharma isn’t stepping up to make a coronavirus vaccine; Chinese drug maker threatens Gilead patent
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT Plus: Pharmalittle: Two more Alzheimer’s drugs fail in studies; how Democratic candidates differ on lowering drug costs
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Pharmalittle: Novartis lottery for gene therapy begins amid tough questions; coronavirus vaccine may take a year
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Pharmalittle: Trump claims on drug prices are mostly false; Merck to spin off old drugs into new company
Good morning, everyone, and welcome to the middle of the week, which arrived rather quickly,…
STAT Plus: Pharmalittle: France indicts Sanofi over epilepsy drug risks; Trump talk of drug pricing in SOTU speech may backfire
Hello, everyone, and how are you today? We are doing just fine, thank you, despite…
STAT Plus: If Medicare negotiated insulin prices like the VA, it could have saved billions
As insulin becomes a poster child for the growing outcry over the cost of medicines,…
STAT Plus: Pharmalittle: FDA approves peanut allergy drug; employer coalition likes House drug pricing bill
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Pharmalittle: Trump gives states a tool to lower drug costs, with a catch; ICER updates how it assesses drugs
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Pharmalittle: Drug prices forecast to rise 3.6%; House committee considers bill to update generic labels
Rise and shine, everyone, another busy day is on the way. Our short person has…
STAT Plus: Pharmalittle: Novartis says coronavirus not disrupting supply chain, for now; FDA releases new gene therapy policies
Good morning, everyone, and welcome to the middle of the week. You made it this…
STAT Plus: Pharmalittle: Insulin dominates Democrats’ health agenda in Iowa; FDA studies Instagram influencers
Good morning, everyone. The world is watching China, the new coronavirus, and the outbreak’s spread….
STAT Plus: Pharmalittle: Coronavirus spread may hurt pharma’s supply chain; Illinois limits out-of-pocket insulin costs
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Pharmalittle: Drug makers spent $120 million lobbying Congress in 2019; more investors are bullish in Biogen’s Alzheimer drug
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Pharmalittle: Most Americans worry about drug prices, not Medicare for All; FDA remains divided over a drug
Top of the morning to you, and a fine one it is. Our short person…
STAT Plus: Pharmalittle: Connecticut lawmakers look to cap insulin prices; Glaxo halts Excedrin production
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT Plus: Pharmalittle: Indian drug makers receive most FDA warning letters; most clinical trial results go unreported
Hello, everyone, and nice to see you again. We have finally returned from an extended…
STAT Plus: Pharmalittle: FTC member favors Medicare negotiation on drug prices; BioMarin weighs pricing world’s most expensive drug
Good morning. Elizabeth Cooney here again, channeling Ed Silverman as another week draws to a…
STAT Plus: Pharmalittle: Roche plans aggressive SMA drug pricing; where are those clinical trial results?
Good morning. Elizabeth Cooney here in Boston while Ed Silverman hobnobs with industry types at…
STAT Plus: Pharmalittle: AstraZeneca fish oil pill flops; boom in biopharma dealmaking predicted for 2020
Good morning. Elizabeth Cooney sitting in for Ed Silverman, who is covering the J.P. Morgan…
STAT Plus: Pharmalittle: Combining antibiotics may cause resistance; Lilly moves into dermatitis market with $1.1 billion deal
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Pharmalittle: More companies recall heartburn tablets; Merck’s Keytruda wins another cancer approval
Top of the morning to you, and a fine one, it is, thanks to clear…
STAT Plus: Pharmalittle: More companies recall heartburn tablets; Merck’s Keytruda wins another cancer approval
Top of the morning to you, and a fine one, it is, thanks to clear…
STAT Plus: Pharmalittle: Execs vow to place patients ahead of profits; conservatives like Republican drug pricing bill
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT Plus: Pharmalittle: Few vets were treated with antidepressant Trump touted; Pelosi lashes out at price hikes
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Pharmalittle: Lab urges FDA to recall all forms of Zantac; end-of-year FDA approval rush has unintended consequence
And so, another working week will soon draw to a close. A little quicker than…
STAT Plus: Pharmalittle: FDA failed to police opioid prescribing program; Novo launches plan to mitigate insulin cost
Good morning, everyone, and welcome to a new year. We hope the extended respite —…